Stueland Katherine
5 of 10 shown
The 5 most recent of 10 visible filings, newest first.
- GeneDx Holdings Corp. Chief executive officer18,750 sharesOption exercise
- GeneDx Holdings Corp. Chief executive officer$300,846Open-market sale
- GeneDx Holdings Corp. Chief executive officer$406,936Open-market sale
- GeneDx Holdings Corp. Chief executive officer$147,774Open-market sale
- GeneDx Holdings Corp. Chief executive officer$14,120Open-market sale